BrightSpring Q2 2026: Revenue Jumps 23%, Net Income Surges to $87M, Leverage Drops to 2.15x
BTSG has more than doubled off its 52-week low of $19.01.
Summary
BrightSpring reported Q2 2026 revenue of $3.87B (+23% YoY) and net income of $86.6M, driven by strong pharmacy and provider growth. Leverage fell to 2.15x after a $300M debt paydown.
Key Events · Earnings and Guidance · BTSG
-
Revenue Surges 23% to $3.87B
Q2 2026 total revenue grew 23% year-over-year to $3.87 billion, with Pharmacy Solutions up 22% to $3.4 billion and Provider Services up 30% to $466 million, driven by specialty drug volume and the Amedisys acquisition.
-
Net Income Swings to $86.6M
Net income from continuing operations was $86.6 million, compared to $8.5 million in Q2 2025. Diluted EPS from continuing operations rose to $0.39 from $0.04.
-
Adjusted EBITDA Up 44% to $205.5M
Adjusted EBITDA increased 44.2% to $205.5 million, with segment EBITDA growth of 44% in Pharmacy Solutions and 33% in Provider Services.
-
Leverage Reduced to 2.15x After $300M Debt Paydown
The company used proceeds from the Community Living divestiture to repay $300 million of term debt and refinanced the remaining balance at SOFR + 2.00%, reducing leverage from 2.99x at year-end 2025 to 2.15x.
Analysis · BTSG · Industrial Applications And Services
A blowout quarter underscores BrightSpring's accelerating momentum. Revenue climbed 23% to $3.87 billion, while net income from continuing operations swung dramatically from $8.5 million to $86.6 million. Both segments delivered robust growth—Pharmacy Solutions revenue rose 22% on specialty drug volume, and Provider Services grew 30%, boosted by the Amedisys acquisition. Proceeds from the Community Living divestiture allowed the company to pay down $300 million in debt and refinance its term loan at a lower rate, cutting leverage to 2.15x. Liquidity now stands at over $1 billion. The results confirm the business is scaling profitably and deleveraging rapidly, though the secondary offering by KKR and management in June signals ongoing sponsor exit.
At the time of this filing, BTSG was trading at $73.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $14.3B. The 52-week trading range was $19.01 to $73.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.